100 related articles for article (PubMed ID: 11578774)
1. Functional role of TGF beta in Alzheimer's disease microvascular injury: lessons from transgenic mice.
Masliah E; Ho G; Wyss-Coray T
Neurochem Int; 2001; 39(5-6):393-400. PubMed ID: 11578774
[TBL] [Abstract][Full Text] [Related]
2. Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice.
Wyss-Coray T; Lin C; Sanan DA; Mucke L; Masliah E
Am J Pathol; 2000 Jan; 156(1):139-50. PubMed ID: 10623661
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease-like cerebrovascular pathology in transforming growth factor-beta 1 transgenic mice and functional metabolic correlates.
Wyss-Coray T; Lin C; von Euw D; Masliah E; Mucke L; Lacombe P
Ann N Y Acad Sci; 2000 Apr; 903():317-23. PubMed ID: 10818521
[TBL] [Abstract][Full Text] [Related]
4. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
5. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease.
Wyss-Coray T; Masliah E; Mallory M; McConlogue L; Johnson-Wood K; Lin C; Mucke L
Nature; 1997 Oct; 389(6651):603-6. PubMed ID: 9335500
[TBL] [Abstract][Full Text] [Related]
6. Molecular and functional dissection of TGF-beta1-induced cerebrovascular abnormalities in transgenic mice.
Buckwalter M; Pepper JP; Gaertner RF; Von Euw D; Lacombe P; Wyss-Coray T
Ann N Y Acad Sci; 2002 Nov; 977():87-95. PubMed ID: 12480736
[TBL] [Abstract][Full Text] [Related]
7. Cerebrovascular pathology during the progression of experimental Alzheimer's disease.
Giannoni P; Arango-Lievano M; Neves ID; Rousset MC; Baranger K; Rivera S; Jeanneteau F; Claeysen S; Marchi N
Neurobiol Dis; 2016 Apr; 88():107-17. PubMed ID: 26774030
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.
Wyss-Coray T; Lin C; Yan F; Yu GQ; Rohde M; McConlogue L; Masliah E; Mucke L
Nat Med; 2001 May; 7(5):612-8. PubMed ID: 11329064
[TBL] [Abstract][Full Text] [Related]
9. Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease.
Mattson MP; Barger SW; Furukawa K; Bruce AJ; Wyss-Coray T; Mark RJ; Mucke L
Brain Res Brain Res Rev; 1997 Feb; 23(1-2):47-61. PubMed ID: 9063586
[TBL] [Abstract][Full Text] [Related]
10. Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain.
Grammas P; Ovase R
Am J Pathol; 2002 May; 160(5):1583-7. PubMed ID: 12000710
[TBL] [Abstract][Full Text] [Related]
11. Recent work on Alzheimer's disease transgenics.
Duff K
Curr Opin Biotechnol; 1998 Dec; 9(6):561-4. PubMed ID: 9889140
[TBL] [Abstract][Full Text] [Related]
12. Selective deletion of apolipoprotein E in astrocytes ameliorates the spatial learning and memory deficits in Alzheimer's disease (APP/PS1) mice by inhibiting TGF-β/Smad2/STAT3 signaling.
Zheng JY; Sun J; Ji CM; Shen L; Chen ZJ; Xie P; Sun YZ; Yu RT
Neurobiol Aging; 2017 Jun; 54():112-132. PubMed ID: 28366226
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.
Holtzman DM; Fagan AM; Mackey B; Tenkova T; Sartorius L; Paul SM; Bales K; Ashe KH; Irizarry MC; Hyman BT
Ann Neurol; 2000 Jun; 47(6):739-47. PubMed ID: 10852539
[TBL] [Abstract][Full Text] [Related]
14. Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology.
Apelt J; Schliebs R
Brain Res; 2001 Mar; 894(1):21-30. PubMed ID: 11245811
[TBL] [Abstract][Full Text] [Related]
15. Peripheral Tumor Necrosis Factor-Alpha (TNF-α) Modulates Amyloid Pathology by Regulating Blood-Derived Immune Cells and Glial Response in the Brain of AD/TNF Transgenic Mice.
Paouri E; Tzara O; Kartalou GI; Zenelak S; Georgopoulos S
J Neurosci; 2017 May; 37(20):5155-5171. PubMed ID: 28442538
[TBL] [Abstract][Full Text] [Related]
16. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
Paouri E; Tzara O; Zenelak S; Georgopoulos S
J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
[TBL] [Abstract][Full Text] [Related]
17. Cromolyn Reduces Levels of the Alzheimer's Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis.
Zhang C; Griciuc A; Hudry E; Wan Y; Quinti L; Ward J; Forte AM; Shen X; Ran C; Elmaleh DR; Tanzi RE
Sci Rep; 2018 Jan; 8(1):1144. PubMed ID: 29348604
[TBL] [Abstract][Full Text] [Related]
18. NSAID and antioxidant prevention of Alzheimer's disease: lessons from in vitro and animal models.
Cole GM; Morihara T; Lim GP; Yang F; Begum A; Frautschy SA
Ann N Y Acad Sci; 2004 Dec; 1035():68-84. PubMed ID: 15681801
[TBL] [Abstract][Full Text] [Related]
19. Venular degeneration leads to vascular dysfunction in a transgenic model of Alzheimer's disease.
Lai AY; Dorr A; Thomason LA; Koletar MM; Sled JG; Stefanovic B; McLaurin J
Brain; 2015 Apr; 138(Pt 4):1046-58. PubMed ID: 25688079
[TBL] [Abstract][Full Text] [Related]
20. Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice.
Wyss-Coray T; Yan F; Lin AH; Lambris JD; Alexander JJ; Quigg RJ; Masliah E
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10837-42. PubMed ID: 12119423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
